ACTRN12623000226606
招募中
未知
DYNAMALK: Dynamic ctDNA profiling in ALK+ Non-Small Cell Lung Cancer (NSCLC) : a study of the Australian Registry and Biobank of Thoracic Cancers (AURORA)
Peter MacCallum Cancer Centre0 个研究点目标入组 55 人2023年3月3日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Advanced ALK+ NSCLC
- 发起方
- Peter MacCallum Cancer Centre
- 入组人数
- 55
- 状态
- 招募中
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Arm A: advanced ALK\+ patients, treatment naïve planned to start lorlatinib
- •Arm B: advanced ALK\+ patients, pre\-treated at resistance to any prior ALK directed line of treatment
- •DYNAMALK is an AURORA sub\-study with participation requiring enrolment in AURORA. All existing AURORA participants will be screened for DYNAMALK eligibility and offered participation. Non\-AURORA patients can be enrolled into AURORA by their treating clinician specifically to participate in DYNAMALK.
排除标准
- •Diagnosis other than ALK\+ NSCLC
结局指标
主要结局
未指定
相似试验
招募中
不适用
Implementation of up-front ctDNA analysis into lung cancer care and development of liquid biopsy-based decision support models - the Lungmarker2 studylung cancerlung carcinoma10029107NL-OMON53764Catharina-ziekenhuis800
已完成
不适用
ongkankernet implementation ctDNA AnalysisNL-OMON50777Radboud Universitair Medisch Centrum250
招募中
不适用
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast CancerMetastatic Invasive Lobular Carcinoma (mILC)NCT06666439Julia Foldi20
招募中
不适用
ongitudinal characterization of circulating DNA in serum of patients after allogenic bone augmentatioPatients in need of bone augmentation prior dental implant placementDRKS00013010niversitätsklinikum Hamburg-EppendorfInstitut für Tumorbiologie35
招募中
不适用
Clinical efficacy of ctDNA dynamics before and after total neoadjuvant treatment in locally adjuvant rectal cancer.KCT0008155Chonnam National University Hospital Hwasun Hospital45